Eximis Surgical is developing a laparoscopic specimen removal system for minimally invasive surgery (MIS) designed to fully contain specimen segmentation and removal. Eximis secured $8.7M in financing from Olympus Innovation Ventures to fund U.S. regulatory and IDE clinical trial activities. We are partnering with Donna Ford-Serbu, CEO of Eximis Surgical, to hire our Head of Regulatory.
Technology Video: Specimen Segmentation and Removal
This position will be the first internal full-time regulatory employee responsible for managing all FDA interactions while owning regulatory activities for the IDE and De Novo pathways. Additionally, this position will be the hands-on and strategic leader responsible for internalizing the regulatory and clinical activities while supporting CRO selection and management.
This is a remote-based position which will require monthly travel to the Headquarters in Colorado and reports directly to the CEO.
Bachelor’s degree in science related field.
Eximis Surgical Inc., develops innovative technologies for the removal of large specimens during minimally invasive procedures. The company is in the pre-market phase and is actively working towards FDA submission for its first device in the platform. Eximis Surgical’ proprietary technology is designed to provide surgeons a fully automated and contained system that leverages controlled RF energy delivery to segment large tissue specimens for removal through a small incision.
Co-Founder & CEO
Lifeblood™ supports global MedTech Startups with Talent Acquisition and Fundraising Strategies. We build full-scale startup teams from Board and C-level executives to entry-level individual contributors and from early-stage R&D through multi-national commercialization phases.Approaching two decades of experience in the MedTech industry, our talent acquisition services and team-building efforts are the results of 2,000+ successful hires for 500+ companies in 6 continents. We have facilitated more than $220 million for MedTech startups with our fundraising strategies and global investor network.
People and money are the lifeblood capital of startups. Learn from our entrepreneurs and investors as we demystify raising and investing capital on our MedTech Money Podcast Series.